REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

CTL Software Kft. (Hungary)

Main Activities: Computer Systems Design and Related Services
Full name: CTL Software Development Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Cellular Technology Limited is a biotechnology company specializing in cellular immune monitoring. The company develops ImmunoSpot technology and offers ImmunoSpot ELISPOT Kits and TVA Software suite. The company has developed and validated various customized T cell ELISPOT assays for pharmaceutical and biotechnology clients. Additionally, Cellular Technology Limited offers factory refurbished analyzers and analysis services.

Headquarters
Vago utca 2.
Kecskemet; Bacs-Kiskun; Postal Code: 6000

Contact Details: Purchase the CTL Software Kft. report to view the information.

Website: http://www.immunospot.com

Basic Information
Total Employees:
Purchase the CTL Software Kft. report to view the information.
Outstanding Shares:
Purchase the CTL Software Kft. report to view the information.
Incorporation Date:
January 21, 2009
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after CTL Software Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
81.37%▲
Total operating revenue
81.38%▲
Operating profit (EBIT)
3418.85%▲
EBITDA
1076.98%▲
Net Profit (Loss) for the Period
N/A
Total assets
45.08%▲
Total equity
47.52%▲
Operating Profit Margin (ROS)
15.26%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.77%▼
Cash Ratio
-0.14%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo